HRX Pitch Competition: Deadline Extended to July 17, 2024

HRX Pitch Competition: Deadline Extended to July 17, 2024

Lars Grieten

CEO & Co-Founder


Speaker Sessions

September 07, 2024 | 08:15 AM (EDT) - 09:00 AM (EDT)

About Lars Grieten, MSc

Lars Grieten is a Belgian entrepreneur and digital health technology innovator. As the co-founder and CEO of FibriCheck, he has revolutionized cardiovascular care with a pioneering AI platform that uses smartphones and wearables for heart rhythm monitoring. This device-agnostic solution has made heart monitoring more accessible, benefiting over 1.2 million users globally.

FibriCheck has developed a software-as-a-medical-device enabling users to monitor their heart health via smartphone cameras, aiding in early detection of conditions like atrial fibrillation (AFib). The platform’s scalability and compatibility with over 11,000 smartphone models have made it a standout in the market, backed by extensive clinical validation with over 70 peer-reviewed publications and proven health economic benefits.

Grieten’s vision emphasizes early detection, management, and predictive care, utilizing ubiquitous and cost-effective solutions to enhance patient outcomes and healthcare efficiency. FibriCheck’s AI models utilize over 15 million annotated datasets to detect various arrhythmias, surpassing traditional care methods. The company has also secured multiple regulatory approvals, creating a global footprint.

In addition to his entrepreneurial ventures, Grieten serves as a visiting professor in digital health at Hasselt University. He frequently shares his insights at industry events, inspiring future innovators in healthcare technology. His contributions continue to drive advancements in digital health, positioning FibriCheck as a leader in the field.